Both in Biotechnology
LENZ Therapeutics vs Armata Pharmaceuticals
Over the past year LENZ returned −87.3% and ARMP returned −37.9%; their daily moves had a correlation of 0.09.
LENZ −87.3% ARMP −37.9%Growth of $1, one year, split-adjusted
| Metric | LENZ | ARMP |
|---|---|---|
| Price | $3.55 | $3.00 |
| Market cap | $111.5M | $111.5M |
| Today | +16.39% | +5.26% |
| 1 month | −1.1% | −18.0% |
| 6 months | −60.9% | −67.9% |
| Year to date | −77.8% | −52.2% |
| 1 year | −88.1% | −38.9% |
| Revenue growth (YoY) | +9.7% | +15.7% |
| Gross margin | 94.9% | 100.0% |
| Net margin | −581.8% | 2953.8% |
| P/E (TTM) | — | — |
| Price / sales | 5.2× | 20.1× |
| Net cash | $220.0M | -$259.6M |
| Dividend yield | — | — |
| Volatility (60d) | 77.2% | 115.0% |
| Short % of float | 46.7% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).